Results 121 to 130 of about 29,391 (230)

Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. [PDF]

open access: yesClin Infect Dis, 2023
Levitt JE   +19 more
europepmc   +1 more source

Role of leukotriene B4 (LTB4)-LTB4 receptor 1 signaling in post-incisional nociceptive sensitization and local inflammation in mice. [PDF]

open access: yesPLoS One, 2022
Asahara M   +7 more
europepmc   +1 more source

n-3 Polyunsaturated Fatty Acids Modulate LPS-Induced ARDS and the Lung-Brain Axis of Communication in Wild-Type versus Fat-1 Mice Genetically Modified for Leukotriene B4 Receptor 1 or Chemerin Receptor 23 Knockout. [PDF]

open access: yesInt J Mol Sci, 2023
Hernandez J   +15 more
europepmc   +1 more source

Transcellular biosynthesis of leukotriene B4 orchestrates neutrophil swarming to fungi. [PDF]

open access: yesiScience, 2022
Hopke A   +9 more
europepmc   +1 more source

Leukotriene B4 in Inflammatory Bowel Disease

open access: yesCanadian Journal of Gastroenterology, 1993
William F Stenson
doaj   +1 more source

Human Orphan Cytochrome P450 2U1 Catalyzes the ω-Hydroxylation of Leukotriene B4. [PDF]

open access: yesInt J Mol Sci, 2022
Nouri K   +5 more
europepmc   +1 more source

Dual inhibition of complement component 5 and leukotriene B4 by topical rVA576 in atopic keratoconjunctivis: TRACKER phase 1 clinical trial results. [PDF]

open access: yesOrphanet J Rare Dis, 2021
Sánchez-Tabernero S   +6 more
europepmc   +1 more source

Leukotriene B4 regulates T cell recognition and control of MCMV in mucosal tissues. [PDF]

open access: yesMucosal Immunol
Springer LE   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy